Craig Sommerville, senior vice president of the MDI Business Unit at Kindeva, discusses the drivers behind the industry-wide shift to NGPs with low global warming potential (GWP).
With 2026 on the horizon, pharma leaders are already looking ahead. European Pharmaceutical Manufacturer asked industry voices what they think 2026 will bring, from innovation and AI to regulation and resilience. Here’s what they had to say.
Olivia Friett, editor of European Pharmaceutical Manufacturer, spoke to Luca Cavazzini, sales & marketing director at IMA Active, about the company’s newest developments.
Philip Bradley, general manager at Astoriom shares why robust temperature control is essential to protect product integrity, compliance, and patient safety.
At CPHI Frankfurt, we sat down with Peter Bains, MD & CEO of Syngene International, to discuss the company’s recent investments in peptides and antibody–drug conjugates (ADCs) and the broader evolution of integrated development in biologics.
Dr. Fábio A. S. Leite, subject matter expert for Pharma, Testo Saveris discusses how in the pharmaceutical sector, sensors are the frontline of medicine integrity, safeguarding sterility, maintaining quality and ultimately facilitating patient care.
